Role at ANSTO
Kellie-Anne Farrawell is the Tritium Facility Officer who works within the Isotope Tracing in Natural Systems platform within Nuclear Science and Technology.
Showing 61 - 80 of 508 results
Kellie-Anne Farrawell is the Tritium Facility Officer who works within the Isotope Tracing in Natural Systems platform within Nuclear Science and Technology.
ANSTO may provide travel and accommodation support to successful grant applicants from AINSE member organisations. Travel funds granted are to be used solely to cover the majority of the cost to travel to Sydney.
Nuclear safety expert discusses Fukushima
A limited amount of travel support is available to students from AINSE member institutes to travel to the New User Sympsosium.
Four successful applicants announced for the 2018 AINSE-ANSTO-French Embassy Research Internship Program.
Sample environments, Data analysis.
In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth. However, it is the secondary particles of lower energies created when galactic and cosmic radiation interacts with shielding that is of concern for astronauts.
In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.
Frequently asked questions about the ANSTO Security Process, travel funding, ANSTO Research Portal and ACNS Customer Portal.
ANSTO works in partnerships and collaborative ventures with national and international organisations. Partner with ANSTO.
Sample environments, Data Analysis.
The nandin Innovation Centre and Southern Sydney Innovation Network are excited to host Dr Tiffany Vora, Expert and Vice Chair Digital Biology and Medicine at Singularity University, for two presentations on Diversity and Inclusion and Biotech, along with an interview with DR KC Huang.